Healthcare provider profile · identity verified

Scott A Bangs, MD

Family Practice · OWATONNA, MN · NPI 1912967662

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	378	103
Atorvastatin Calcium	Atorvastatin Calcium	355	112
Metoprolol Succinate	Metoprolol Succinate	222	70
Omeprazole	Omeprazole	216	52
Levothyroxine Sodium	Levothyroxine Sodium	205	45
Metoprolol Tartrate	Metoprolol Tartrate	183	50
Simvastatin	Simvastatin	174	54
Amlodipine Besylate	Amlodipine Besylate	170	58
Gabapentin	Gabapentin	166	33
Hydrochlorothiazide	Hydrochlorothiazide	139	41
Tamsulosin Hcl	Tamsulosin Hcl	122	39
Losartan Potassium	Losartan Potassium	115	37
Sertraline Hcl	Sertraline Hcl	115	26
Furosemide	Furosemide	111	33
Pantoprazole Sodium	Pantoprazole Sodium	110	28
Rosuvastatin Calcium	Rosuvastatin Calcium	110	33
Eliquis	Apixaban	100	18
Metformin Hcl	Metformin Hcl	100	35
Atenolol	Atenolol	98	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	96	32
Glipizide Er	Glipizide	85	27
Pravastatin Sodium	Pravastatin Sodium	82	24
Albuterol Sulfate Hfa	Albuterol Sulfate	73	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	73	18
Warfarin Sodium	Warfarin Sodium	73	19
Allopurinol	Allopurinol	64	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	62	18
Metformin Hcl Er	Metformin Hcl	59	20
Xarelto	Rivaroxaban	53	suppressed
Potassium Chloride	Potassium Chloride	50	12
Trazodone Hcl	Trazodone Hcl	44	21
Citalopram Hbr	Citalopram Hydrobromide	40	suppressed
Fluticasone Propionate	Fluticasone Propionate	38	16
Alprazolam	Alprazolam	36	suppressed
Celecoxib	Celecoxib	35	suppressed
Chlorthalidone	Chlorthalidone	35	suppressed
Diclofenac Sodium	Diclofenac Sodium	35	suppressed
Prednisone	Prednisone	35	16
Oxybutynin Chloride Er	Oxybutynin Chloride	33	suppressed
Ozempic	Semaglutide	33	suppressed
Clonazepam	Clonazepam	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Jardiance	Empagliflozin	32	suppressed
Tramadol Hcl	Tramadol Hcl	32	suppressed
Clopidogrel	Clopidogrel Bisulfate	31	12
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Carvedilol	Carvedilol	30	suppressed
Gemfibrozil	Gemfibrozil	30	suppressed
Famotidine	Famotidine	29	suppressed
Montelukast Sodium	Montelukast Sodium	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Meloxicam	Meloxicam	28	suppressed
Nabumetone	Nabumetone	27	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	26	suppressed
Digoxin	Digoxin	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Lorazepam	Lorazepam	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Diazepam	Diazepam	23	suppressed
Lovastatin	Lovastatin	23	suppressed
Nystatin	Nystatin	23	suppressed
Aripiprazole	Aripiprazole	22	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Lamotrigine	Lamotrigine	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Glimepiride	Glimepiride	19	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Latanoprost	Latanoprost	18	suppressed
Methotrexate	Methotrexate Sodium	18	suppressed
Naproxen	Naproxen	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Divalproex Sodium	Divalproex Sodium	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Topiramate	Topiramate	17	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Lubiprostone	Lubiprostone	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Baclofen	Baclofen	13	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Finasteride	Finasteride	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Glipizide	Glipizide	13	suppressed
Glycopyrrolate	Glycopyrrolate	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Torsemide	Torsemide	13	suppressed
Velivet	Desogestrel-Ethinyl Estradiol	13	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	suppressed
Indomethacin	Indomethacin	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Humulin R	Insulin Regular, Human	11	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	11	suppressed
Propafenone Hcl	Propafenone Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error